Ignite Creation Date:
2025-12-24 @ 4:06 PM
Ignite Modification Date:
2026-01-02 @ 2:12 AM
Study NCT ID:
NCT03163966
Status:
COMPLETED
Last Update Posted:
2021-10-05
First Post:
2017-05-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of the EP4 Antagonist CR6086 in Combination With Methotrexate, in DMARD-naïve Patients With Early Rheumatoid Arthritis
Sponsor:
Rottapharm Biotech
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR6086-2-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None